Citations
2 citation(s) found for "Yee, Angela".
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
Camerini, David , Randall, Arlo, Trappl-Kimmons, Krista, Oberai, Amit , Hung, Christopher, Edgar, Joshua , Shandling, Adam D., Huynh, Vu, Teng, Andy , Hermanson, Gary, Pablo, Jozelyn , Stumpf, Megan M. , Lester, Sandra , Harcourt, Jennifer L. , Tamin, Azaibi , Thornburg, Natalie J. , Satheshkumar, Panayampalli S. , Liang, Xiaowu, Kennedy, Richard B. , Yee, Angela , Townsend, Michael B. , Campo, Joseph J. , Kennedy, Richard , Rasheed, Mohammed
Microbiology Spectrum | October 27, 2021 | Volume: 9 | Issue: 2 | Pages: No page available
10.1128/spectrum.01416-21
| PMID 34704808
With novel mutant SARS-CoV-2 variants of concern on the rise, knowledge of immune specificities against SARS-CoV-2 proteins is increasingly important for understanding the impact of structural changes in antibody-reactive protein epitopes on naturally acquired and vaccine-induced immunity, as well as broader topics of cross-reactivity and viral evolution. A multi-coronavirus protein microarray used to map the binding of COVID-19 patient antibodies to SARS-CoV-2 proteins and protein fragments as well as to the proteins of four other coronaviruses that infect humans has shown specific regions of SARS-CoV-2 proteins that are highly reactive with patient antibodies and revealed cross-reactivity of these antibodies with other human coronaviruses.
Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers
Carter, Simon , Gutman, Talia , Logeman, Charlotte , Cattran, D C, Lightstone, Liz , Bagga, Arvind , Barbour, Sean J. , Barratt, Jonathan , Boletis, John , Caster, Dawn J. , Floege, Jürgen , Hogan, Jonathan J., Lafayette, Richard , Malvar, Ana , Scholes‐Robertson, Nicole , Trimarchi, Hernán, Zhang, Hong , Ažukaitis, Karolis , Viecelli, Andrea K. , Dunn, Louese, Harris, David C.H. , Johnson, David W. , Laboi, Paul, Ryan, Jessica , Ruiz, Lorena , Wang, Angela Yee‐Moon , Lee, Achilles Hoi Kan, Fung, Samuel , Tong, M.K.H. , Teixeira‐Pinto, Armando , Alexander, Stephen I. , Craig, Jonathan C. , Investigators, on behalf of the SONG-GD, Floege, Jürgen , Kitching, A Richard , Johnson, David W , Wang, Angela Yee-Moon , Wilkie, Martin , Carter, Simon A , Barratt, Jonathan , Scholes-Robertson, Nicole , Coppo, Rosanna , Fervenza, Fernando C. , Hladunewich, Michelle , Hogan, Jonathan J. , Kitching, A. Richard , Malvar, Ana , Radhakrishnan, Jai , Rovin, Brad H. , Trimarchi, Hernán , Cho, Yeoungjee , Kerr, Peter G. , Shen, Jenny I. , Tong, Allison , Investigators, on behalf of the SONG-GD
Clinical Journal of the American Society of Nephrology | April 30, 2020 | Volume: 15 | Issue: 5 | Pages: 673-684
10.2215/cjn.13101019
| PMID 32354728
Background and objectives Shared decision making in patients with glomerular disease remains challenging because outcomes important to patients remain largely unknown. We aimed to identify and prioritize outcomes important to patients and caregivers and to describe reasons for their choices. Design, setting, participants, & measurements We purposively sampled adult patients with glomerular disease and their caregivers from Australia, Hong Kong, the United Kingdom, and the United States. Participants identified, discussed, and ranked outcomes in focus groups using the nominal group technique; a relative importance score (between zero and one) was calculated. Qualitative data were analyzed thematically. Results Across 16 focus groups, 134 participants (range, 19–85 years old; 51% women), including 101 patients and 33 caregivers, identified 58 outcomes. The ten highest-ranked outcomes were kidney function (importance score of 0.42), mortality (0.29), need for dialysis or transplant (0.22), life participation (0.18), fatigue (0.17), anxiety (0.13), family impact (0.12), infection and immunity (0.12), ability to work (0.11), and BP (0.11). Three themes explained the reasons for these rankings: constraining day-to-day experience, impaired agency and control over health, and threats to future health and family. Conclusions Patients with glomerular disease and their caregivers highly prioritize kidney health and survival, but they also prioritize life participation, fatigue, anxiety, and family impact.